J.-P. Sauvanet

876 total citations
41 papers, 666 citations indexed

About

J.-P. Sauvanet is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Physiology. According to data from OpenAlex, J.-P. Sauvanet has authored 41 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Genetics and 6 papers in Physiology. Recurrent topics in J.-P. Sauvanet's work include Diabetes Management and Research (14 papers), Diabetes Treatment and Management (9 papers) and Diabetes and associated disorders (7 papers). J.-P. Sauvanet is often cited by papers focused on Diabetes Management and Research (14 papers), Diabetes Treatment and Management (9 papers) and Diabetes and associated disorders (7 papers). J.-P. Sauvanet collaborates with scholars based in France, United Kingdom and Spain. J.-P. Sauvanet's co-authors include Bruno Guerci, Gillian Kreugel, Debbie Hicks, Anders Frid, Kenneth Strauss, C. Letondeur, J. Liersch, Laurence Hirsch, Nadia Tubiana‐Rufi and P Agache and has published in prestigious journals such as British Journal of Anaesthesia, Scandinavian Journal of Gastroenterology and Maturitas.

In The Last Decade

J.-P. Sauvanet

38 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.-P. Sauvanet France	11	378	134	117	97	77	41	666
Kai‐Jen Tien Taiwan	17	286 0.8×	89 0.7×	126 1.1×	35 0.4×	21 0.3×	37	708
Susan M. Sirmans United States	8	164 0.4×	42 0.3×	95 0.8×	17 0.2×	27 0.4×	11	1.2k
Jörg Schnitker Germany	16	272 0.7×	112 0.8×	76 0.6×	27 0.3×	104 1.4×	30	882
Thep Himathongkam Thailand	15	480 1.3×	80 0.6×	98 0.8×	12 0.1×	27 0.4×	70	772
Annette Barnie Canada	12	494 1.3×	159 1.2×	181 1.5×	43 0.4×	27 0.4×	21	934
Stephen R. Newmark United States	14	135 0.4×	26 0.2×	61 0.5×	21 0.2×	21 0.3×	31	476
Peter Hammond United Kingdom	17	507 1.3×	286 2.1×	582 5.0×	49 0.5×	9 0.1×	46	1.2k
Mehmet Keskın Türkiye	13	204 0.5×	82 0.6×	64 0.5×	42 0.4×	11 0.1×	52	697
Mousa Abujbara Jordan	11	192 0.5×	37 0.3×	68 0.6×	22 0.2×	9 0.1×	24	378
Grigorios Trypsianis Greece	15	55 0.1×	24 0.2×	186 1.6×	32 0.3×	19 0.2×	72	834

Countries citing papers authored by J.-P. Sauvanet

Since Specialization

Citations

This map shows the geographic impact of J.-P. Sauvanet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Sauvanet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Sauvanet more than expected).

Fields of papers citing papers by J.-P. Sauvanet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Sauvanet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Sauvanet. The network helps show where J.-P. Sauvanet may publish in the future.

Co-authorship network of co-authors of J.-P. Sauvanet

This figure shows the co-authorship network connecting the top 25 collaborators of J.-P. Sauvanet. A scholar is included among the top collaborators of J.-P. Sauvanet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-P. Sauvanet. J.-P. Sauvanet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sauvanet, J.-P., et al.. (2019). De la « force » du sang à l’hypertension artérielle : naissance d’une maladie-facteur de risque. Médecine des Maladies Métaboliques. 13(5). 465–471. 1 indexed citations

Sauvanet, J.-P.. (2017). 25e anniversaire pour le Centre Européen d’Étude du Diabète (CeeD) de Strasbourg. Médecine des Maladies Métaboliques. 11(1). 96–96.

Sauvanet, J.-P.. (2012). [Technological innovation in diabetes: is it suitable for everyone and at what price?].. PubMed. S24–8. 1 indexed citations

Gautier, Jean–François & J.-P. Sauvanet. (2011). Efficacy of saxagliptin as an add-on to oral monotherapy in the phase 3 clinical development program: Predictive factors of the treatment response in type 2 diabetes. Annales d Endocrinologie. 72(4). 287–295. 5 indexed citations

Frid, Anders, Laurence Hirsch, Debbie Hicks, et al.. (2010). New injection recommendations for patients with diabetes. Diabetes & Metabolism. 36. S3–S18. 134 indexed citations

Frid, Anders, Laurence Hirsch, Debbie Hicks, et al.. (2010). The Third Injection Technique Workshop In Athens (TITAN). Diabetes & Metabolism. 36. S19–S29. 20 indexed citations

Sauvanet, J.-P.. (2010). Consensus ADA/EASD 2009 : l’algorithme pour le traitement médical du diabète de type 2 est utile !. Médecine des Maladies Métaboliques. 4(2). 181–190.

Bonnet, Fabrice & J.-P. Sauvanet. (2009). Inhibiteurs du cotransporteur sodium-glucose de type 2 (SGLT2) : une nouvelle approche thérapeutique pour le diabète de type 2 ?. Médecine des Maladies Métaboliques. 3(4). 422–429. 1 indexed citations

Drouin, P, J F Blicklé, B Charbonnel, et al.. (2008). DIAGNOSTIC ET CLASSIFICATION DU DIABÈTE SUCRÉ LES NOUVEAUX CRITÈRES. 39(1). 29–39. 3 indexed citations

10.

Schlienger, J.-L. & J.-P. Sauvanet. (2008). Consommation alimentaire des Français : vers un léger mieux d’après INCA2…. Médecine des Maladies Métaboliques. 2(5). 528–530. 2 indexed citations

11.

Sauvanet, J.-P.. (2007). Prise en charge de l’obésité : les centres référents pour la priseen charge de l’obésité à l’AP-HP. Médecine des Maladies Métaboliques. 1(2). 11–11. 1 indexed citations

12.

Guerci, Bruno & J.-P. Sauvanet. (2005). Subcutaneous insulin: pharmacokinetic variability and glycemic variability. Diabetes & Metabolism. 31(4). 4S7–4S24. 87 indexed citations

13.

Sauvanet, J.-P.. (2004). [Altering lifestyle and treating obesity, preventing type 2 diabetes?].. PubMed. 19–24. 2 indexed citations

14.

Monnier, Louis & J.-P. Sauvanet. (2004). Pioglitazone, insulinosensibilité et diabète de type 2 : données récentes. Annales d Endocrinologie. 65(2). 136–148. 5 indexed citations

15.

Valensi, P., J Gautier, G. Amarenco, et al.. (1997). Neuropathie autonome chez le diabétique. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases.. Diabetes & Metabolism. 23(1). 89–99. 2 indexed citations

16.

Creidi, Pierre, et al.. (1994). Effect of a conjugated oestrogen (Premarin®) cream on ageing facial skin. a Comparative study with a placebo cream. Maturitas. 19(3). 211–223. 78 indexed citations

17.

Forster, Alain, et al.. (1990). PREOPERATIVE SEDATION BEFORE REGIONAL ANAESTHESIA: COMPARISON BETWEEN ZOLPIDEM, MIDAZOLAM AND PLACEBO. British Journal of Anaesthesia. 64(6). 670–674. 19 indexed citations

18.

Sauvanet, J.-P., et al.. (1988). Imidazopyridines in sleep disorders : a novel experimental and therapeutic approach. Raven Press eBooks. 47 indexed citations

19.

Braillon, Alain, et al.. (1988). Comparative Haemodynamic Effects of Betaxolol and Propranolol in Patients with Cirrhosis. Scandinavian Journal of Gastroenterology. 23(6). 691–695. 19 indexed citations

20.

Terzano, M. G., et al.. (1988). Les traces alternants cycliques. une nouvelle approche en pharmacologie du sommeil. Neurophysiologie Clinique. 18(5). 447–457. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact